CPIX Share Price

Open 5.46 Change Price %
High 5.59 1 Day 0.07 1.29
Low 5.46 1 Week -0.03 -0.54
Close 5.51 1 Month 0.54 10.87
Volume 16889 1 Year -0.07 -1.25
52 Week High 5.79
52 Week Low 0.00
CPIX Important Levels
Resistance 2 5.63
Resistance 1 5.58
Pivot 5.52
Support 1 5.44
Support 2 5.39
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)

CPIX Technical Analysis 5
As on 2nd Dec 2016 CPIX Share Price closed @ 5.51 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.77 & Strong Buy for SHORT-TERM with Stoploss of 5.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
CPIX Target for December
1st Target up-side 6.05
2nd Target up-side 6.44
3rd Target up-side 6.82
1st Target down-side 4.95
2nd Target down-side 4.56
3rd Target down-side 4.18
CPIX Other Details
Segment EQ
Market Capital 111605592.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.cumberlandpharma.com
CPIX Address
CPIX
2525 West End Avenue
Suite 950
Nashville, TN 37203
United States
Phone: 615-255-0068
Fax: 615-255-0094
CPIX Latest News
Interactive Technical Analysis Chart Cumberland Pharmaceuticals Inc. ( CPIX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cumberland Pharmaceuticals Inc.
CPIX Business Profile
Cumberland Pharmaceuticals Inc. (Cumberland) is specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Cumberland is focused on acquiring rights to, developing and commercializing prescription products for the hospital care and gastroenterology markets. Its product portfolio includes Acetadote (acetylcysteine) Injection, for the treatment of acetaminophen poisoning, Caldolor (ibuprofen) Injection, for pain and fever, Kristalose (lactulose) for oral solution, a prescription laxative, and Hepatoren (ifetroban) Injection, for the treatment of patients suffering from hepatorenal syndrome (HRS). As of December 31, 2011, Hepatoren was in Phase II clinical development. In November 2011, the Company acquired the remaining rights associated with the Kristalose brand. During the year ended December 31, 2011, Cumberland acquired rights to a late-stage product candidate that it develops under the brand name Hepatoren.